Shopping Cart 0
Cart Subtotal
AED 0

Spanish National Cancer Research Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Spanish National Cancer Research Center (CNIO) is a medical research center that conducts cancer research programs. The center integrates basic and translational cancer research. It conducts various scientific programs, which include molecular oncology program, structural biology and biocomputing program, human cancer genetics program, experimental therapeutics program, biotechnology program and clinical research programs. CNIO carries out clinical trials for various tumor types such as colon cancer, pancreas, lung, breast, kidney, prostate, hematological neoplasms, brain, sarcomas, and others. The center also provides several training programs and courses for medical residents and master degree holders in other biomedical areas. It offers practical laboratory courses for undergraduate students and future technicians. CNIO is headquartered in Madrid, Spain.

Spanish National Cancer Research Center-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Pharma Mar Enters into Agreement with Spanish National Cancer Research Centre 10

Licensing Agreements 11

Merck Enters Into Licensing Agreement With Spanish National Cancer Research Centre 11

Inflection Biosciences Enters Into Licensing Agreement With Spanish National Cancer Research Centre For Kinase Inhibitors 12

Spanish National Cancer Research Center-Key Competitors 13

Spanish National Cancer Research Center-Key Employees 14

Spanish National Cancer Research Center-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Government and Public Interest 16

Aug 20, 2018: CNIO researchers prove that gene therapy vectors carrying the telomerase gene do not increase the risk of cancer in cancer-prone mouse models 16

Jun 11, 2018: A new therapy proves effective against brain metastasis 18

Jun 04, 2018: Deciphering the role of cohesin in genome 3D structure helps understanding tumour cells 20

Apr 17, 2018: A potential setback in the personalised medicine of cancer 21

Apr 13, 2018: A novel precision cancer model opens doors to personalised cancer treatment 23

Feb 14, 2018: A gene that increases the risk of pancreatic cancer controls inflammation in normal tissue 24

Feb 01, 2018: CNIO researchers discover a potential new therapeutic strategy for pancreatic cancer 25

Product News 27

Apr 13, 2018: Generated mouse model offers possibility of personalised cancer treatment 27

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Key Facts 2

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Spanish National Cancer Research Center, Deals By Therapy Area, 2012 to YTD 2018 8

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Pharma Mar Enters into Agreement with Spanish National Cancer Research Centre 10

Merck Enters Into Licensing Agreement With Spanish National Cancer Research Centre 11

Inflection Biosciences Enters Into Licensing Agreement With Spanish National Cancer Research Centre For Kinase Inhibitors 12

Spanish National Cancer Research Center, Key Competitors 13

Spanish National Cancer Research Center, Key Employees 14

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Spanish National Cancer Research Center, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Spanish National Cancer Research Center (CNIO) is a medical research center that conducts cancer research programs. The center integrates basic and translational cancer research. It conducts various scientific programs, which include molecular oncology program, structural biology and biocomputing program, human cancer genetics program, experimental therapeutics program, biotechnology program and clinical research programs. CNIO carries out clinical trials for various tumor types such as colon cancer, pancreas, lung, breast, kidney, prostate, hematological neoplasms, brain, sarcomas, and others. The center also provides several training programs and courses for medical residents and master degree holders in other biomedical areas. It offers practical laboratory courses for undergraduate students and future technicians. CNIO is headquartered in Madrid, Spain.

Spanish National Cancer Research Center-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Pharma Mar Enters into Agreement with Spanish National Cancer Research Centre 10

Licensing Agreements 11

Merck Enters Into Licensing Agreement With Spanish National Cancer Research Centre 11

Inflection Biosciences Enters Into Licensing Agreement With Spanish National Cancer Research Centre For Kinase Inhibitors 12

Spanish National Cancer Research Center-Key Competitors 13

Spanish National Cancer Research Center-Key Employees 14

Spanish National Cancer Research Center-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Government and Public Interest 16

Aug 20, 2018: CNIO researchers prove that gene therapy vectors carrying the telomerase gene do not increase the risk of cancer in cancer-prone mouse models 16

Jun 11, 2018: A new therapy proves effective against brain metastasis 18

Jun 04, 2018: Deciphering the role of cohesin in genome 3D structure helps understanding tumour cells 20

Apr 17, 2018: A potential setback in the personalised medicine of cancer 21

Apr 13, 2018: A novel precision cancer model opens doors to personalised cancer treatment 23

Feb 14, 2018: A gene that increases the risk of pancreatic cancer controls inflammation in normal tissue 24

Feb 01, 2018: CNIO researchers discover a potential new therapeutic strategy for pancreatic cancer 25

Product News 27

Apr 13, 2018: Generated mouse model offers possibility of personalised cancer treatment 27

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Key Facts 2

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Spanish National Cancer Research Center, Deals By Therapy Area, 2012 to YTD 2018 8

Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Pharma Mar Enters into Agreement with Spanish National Cancer Research Centre 10

Merck Enters Into Licensing Agreement With Spanish National Cancer Research Centre 11

Inflection Biosciences Enters Into Licensing Agreement With Spanish National Cancer Research Centre For Kinase Inhibitors 12

Spanish National Cancer Research Center, Key Competitors 13

Spanish National Cancer Research Center, Key Employees 14

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Spanish National Cancer Research Center, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.